| Dr Joseph Frank Ceravolo, MD | |
|
1240 Brookstone Centre Parkway, Columbus, GA 31904-2988 | |
| (706) 323-8127 | |
| (706) 596-4837 |
| Full Name | Dr Joseph Frank Ceravolo |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 1240 Brookstone Centre Parkway, Columbus, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508857038 | NPI | - | NPPES |
| BCBS | Other | AL | MONTGOMERY SURGERY CENTER |
| 00979349A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | GA 052155 (Georgia) | Primary |
| Entity Name | Eye Health Partners Of Alabama Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619923745 PECOS PAC ID: 4385530740 Enrollment ID: O20040227000240 |
News Archive
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn't want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.
Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.
The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
| Entity Name | North Columbus Eye Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831251826 PECOS PAC ID: 9931201522 Enrollment ID: O20070228000529 |
News Archive
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn't want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.
Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.
The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
| Entity Name | North Columbus Eye Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1831251826 PECOS PAC ID: 9931201522 Enrollment ID: O20091215000629 |
News Archive
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn't want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.
Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.
The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
| Entity Name | Auburn Lasik & Eye Institute, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730441601 PECOS PAC ID: 7214175835 Enrollment ID: O20130521000300 |
News Archive
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn't want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.
Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.
The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Frank Ceravolo, MD 1240 Brookstone Centre Parkway, Columbus, GA 31904-2988 Ph: (706) 323-8127 | Dr Joseph Frank Ceravolo, MD 1240 Brookstone Centre Parkway, Columbus, GA 31904-2988 Ph: (706) 323-8127 |
News Archive
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn't want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
For the 20 percent of Americans who suffer from chronic pain, prescription opioids may bring relief, but also risks. An estimated 21 to 29 percent of patients who receive chronic opioid treatment will misuse their medications, and 8 to 12 percent will develop an opioid use disorder.
Roche and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays.
The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
James G Brooks Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Dr. Steven Lloyd Henslee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2012 10th Ave, Columbus, GA 31901 Phone: 706-324-4321 Fax: 706-324-4385 | |
Dr. William Jay White, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1030 13th St, Columbus, GA 31901 Phone: 706-327-8181 Fax: 706-596-6658 | |
Bret Crumpton, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Sterling L Cannon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Nicholas Duquette Mayfield, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 |